NCT03676257View on ClinicalTrials.gov

Survival Endpoints for Treatment Evaluation in Subjects Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

UnknownOBSERVATIONAL

Enrollment

20,000

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Cancer

Interventions

OTHER

Endocrine therapies

No intervention

Trial Locations (1)

33076

Insitut Bergonié, Bordeaux

Sponsors

Lead Sponsor

Institut Bergonié

All Listed Sponsors

collaborator

UNICANCER

OTHER

collaborator

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

lead

Institut Bergonié

OTHER